Plasma Cell Neoplasm
📧 Sign up to get email alerts when something new happens for Plasma Cell Neoplasm.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-06-11Clinical Trial Update: Rituximab and Cyclophosphamide in Treating Patients With High Risk, Refractory, or Relapsed Multiple Myeloma [Phase 2]
Phase 2 clinical trial evaluating the combination of rituximab and cyclophosphamide in patients with high-risk, refractory, or relapsed mult…
-
CLINICAL_TRIALS trial_result · 2014-12-31Clinical Trial Update: PAD. ICORG 05-01, V11 [Phase 2]
Phase 2 trial ICORG 05-01 for multiple myeloma and plasma cell neoplasm has completed.
-
CLINICAL_TRIALS trial_result · 2014-10-27Clinical Trial Update: Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy [Phase 1]
Phase 1 safety study of CLT-008 human myeloid progenitor cells after cord blood transplantation for hematologic malignancies has completed.
-
CLINICAL_TRIALS trial_result · 2014-05-02Clinical Trial Update: Donor Bone Marrow Transplantation in Treating Patients With Hematologic Cancer [Phase 2]
Phase 2 trial evaluating donor bone marrow transplantation for hematologic cancers has completed; the study enrolled patients with leukemia,…
-
CLINICAL_TRIALS trial_result · 2014-05-02Clinical Trial Update: Interleukin-2 Following Bone Marrow Transplantation in Treating Patients With Hematologic Cancer [Phase 1]
Phase 1 trial evaluating Interleukin-2 after bone marrow transplantation for hematologic cancers has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-04-17Clinical Trial Update: Laboratory-Treated Donor Bone Marrow in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer [Phase 3]
Phase 3 trial update evaluating laboratory-treated donor bone marrow in patients undergoing donor stem cell transplant for hematologic cance…
-
CLINICAL_TRIALS trial_result · 2014-04-04Clinical Trial Update: Dexamethasone With or Without Thalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma [Phase 3]
Phase 3 trial evaluating dexamethasone with or without thalidomide in newly diagnosed multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2014-01-16Clinical Trial Update: Brostallicin in Treating Patients With Recurrent or Refractory Multiple Myeloma [Phase 1, Phase 2]
Phase 1/2 clinical trial of brostallicin for recurrent or refractory multiple myeloma and related plasma cell neoplasms has completed enroll…
-
CLINICAL_TRIALS trial_result · 2014-01-06Clinical Trial Update: Dexamethasone With or Without Oblimersen in Treating Patients With Relapsed or Refractory Multiple Myeloma [Phase 3]
Phase 3 trial evaluating dexamethasone with or without oblimersen for relapsed or refractory multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2014-01-06Clinical Trial Update: Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Other B-cell Cancers [Phase 2]
Phase 2 clinical trial update on peripheral stem cell transplantation for patients with multiple myeloma and other B-cell cancers, including…
-
CLINICAL_TRIALS trial_result · 2013-12-19Clinical Trial Update: Combination Chemotherapy and Interferon Alfa With or Without Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloma [Phase 3]
Phase 3 trial evaluating the addition of interferon alfa to chemotherapy, with or without bone marrow or peripheral stem cell transplantatio…
-
CLINICAL_TRIALS trial_result · 2013-12-12Clinical Trial Update: Studying T Cells in Blood and Bone Marrow Samples From Patients With Multiple Myeloma
A terminated clinical trial studied T cells in blood and bone marrow from patients with multiple myeloma, with results posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-12-04Clinical Trial Update: Combination Chemotherapy Following GM-CSF in Treating Patients With Multiple Myeloma [Phase 2]
Phase 2 clinical trial evaluating chemotherapy given after GM-CSF for treating multiple myeloma; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2013-11-19Clinical Trial Update: Bortezomib in Treating Patients With Multiple Myeloma Who Have Undergone an Autologous Peripheral Blood Stem Cell Transplant [Phase 1]
Phase 1 clinical trial update evaluating the use of bortezomib in multiple myeloma patients who have undergone autologous peripheral blood s…
-
CLINICAL_TRIALS trial_result · 2013-11-06Clinical Trial Update: Bortezomib, Ascorbic Acid, and Melphalan in Treating Patients With Newly Diagnosed Multiple Myeloma [Phase 2]
Phase 2 study evaluating the combination of bortezomib, ascorbic acid, and melphalan in newly diagnosed multiple myeloma patients. The trial…
-
CLINICAL_TRIALS trial_result · 2013-11-06Clinical Trial Update: Fluphenazine in Treating Patients With Refractory Advanced Multiple Myeloma [Phase 1, Phase 2]
This is a completed Phase 1/2 clinical trial evaluating fluphenazine in patients with refractory advanced multiple myeloma.
-
CLINICAL_TRIALS trial_result · 2013-09-23Clinical Trial Update: Treated T Cells Followed by a Stem Cell Transplant in Treating Patients With Multiple Myeloma [Phase 1]
Phase 1 clinical trial update reporting treated T cells followed by a stem cell transplant in patients with multiple myeloma. The study stat…
-
CLINICAL_TRIALS trial_result · 2013-09-20Clinical Trial Update: Samarium 153 and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma [Phase 1]
Phase 1 clinical trial evaluating Samarium-153 in combination with Bortezomib in patients with relapsed or refractory multiple myeloma; the …
-
CLINICAL_TRIALS trial_result · 2013-09-19Clinical Trial Update: Human Immune Globulin in Treating Patients With Primary Amyloidosis That is Causing Heart Dysfunction [Phase 1, Phase 2]
This clinical trial update covers a Phase 1/2 study evaluating Human Immune Globulin for AL amyloidosis-related heart dysfunction. Results w…
-
CLINICAL_TRIALS trial_result · 2013-09-17Clinical Trial Update: Bortezomib, Doxorubicin Hydrochloride Liposome, and Thalidomide as First-line Therapy in Treating Patients With Previously Untreated Stage I, II, or III Multiple Myeloma [Phase 2]
This Phase 2 trial evaluated a triplet regimen of bortezomib, liposomal doxorubicin, and thalidomide as first-line therapy for patients with…
-
CLINICAL_TRIALS trial_result · 2013-08-12Clinical Trial Update: High-Dose Melphalan and a Second Stem Cell Transplant or Low-Dose Cyclophosphamide in Treating Patients With Relapsed Multiple Myeloma After Chemotherapy [Phase 3]
This Phase 3 clinical trial compares high-dose melphalan with a second stem cell transplant to low-dose cyclophosphamide for patients with r…
-
CLINICAL_TRIALS trial_result · 2013-08-12Clinical Trial Update: High-Dose Chemotherapy and Stem Cell Transplant in Treating Patients With Newly Diagnosed Stage I, Stage II, or Stage III Multiple Myeloma [Phase 2]
This entry describes a Phase 2 clinical trial evaluating high-dose chemotherapy followed by stem cell transplantation in patients with newly…
-
CLINICAL_TRIALS trial_result · 2013-07-18Clinical Trial Update: Combination Chemotherapy in Treating Patients With Multiple Myeloma [Phase 2]
A Phase 2 trial of combination chemotherapy in patients with multiple myeloma and plasma cell neoplasm has completed.
-
CLINICAL_TRIALS trial_result · 2013-07-17Clinical Trial Update: S0232 Dexamethasone With or Without Lenalidomide in Treating Patients With Previously Untreated Stage I, Stage II, or Stage III Multiple Myeloma [Phase 3]
Phase 3 trial S0232 assessed dexamethasone with or without lenalidomide in previously untreated Stage I–III multiple myeloma. The study resu…
-
CLINICAL_TRIALS trial_result · 2013-07-11Clinical Trial Update: SU5416 in Treating Patients With Refractory or Relapsed Multiple Myeloma [Phase 2]
This is a Phase 2 clinical trial update on SU5416 for patients with refractory or relapsed multiple myeloma, with the study status noted as …